AGL
Agilon Health, Inc. · Healthcare · Medical - Care Facilities
Momentum-inputs (vergelijkbare managers):
breedte van houders -15.8% ·
aandelenstroom -25.8% ·
netto nieuwe posities -20.0%
· formule
Brede distributie: dalende aandelen en minder houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 107.72K | $9.13M | n/a | n/a |
| Q2 2026 | 77 | +29 | 8.81M | $943.45M | +30 | −1 |
| Q1 2026 | 49 | -27 | 8.40M | $66.38M | +2 | −29 |
| Q4 2025 | 76 | +1 | 204.25M | $140.72M | +2 | −1 |
| Q3 2025 | 16 | -3 | 177.31M | $182.63M | n/a | −4 |
| Q2 2025 | 17 | +2 | 170.11M | $391.26M | +2 | n/a |
| Q1 2025 | 12 | -1 | 97.37M | $421.60M | +1 | −2 |
| Q4 2024 | 13 | -1 | 128.34M | $243.85M | +1 | −2 |
| Q3 2024 | 13 | +2 | 116.78M | $458.95M | +2 | n/a |
| Q2 2024 | 11 | n/a | 121.97M | $797.68M | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Morgan Stanley ✦ | 59.38M | n/a | $61.17M | 0.0% | n/c | 1 | SEC ↗ ×10 |
| 2 | The Vanguard Group ✦ (passief) | 24.29M | -19.8% | $25.02M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 3 | BlackRock ✦ (passief) | 24.20M | -2.3% | $24.92M | 0.0% | ▼ Trim | 2 | SEC ↗ ×14 |
| 4 | Fidelity (FMR) ✦ | 15.65M | -60.2% | $16.12M | 0.0% | ▼ Trim | 2 | SEC ↗ ×3 |
| 5 | D. E. Shaw & Co. ✦ | 9.99M | +600.9% | $10.29M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 6 | Capital World Investors ✦ | 8.36M | -81.7% | $8.62M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 7 | State Street Global Advisors ✦ (passief) | 7.71M | +0.1% | $7.94M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 8 | Geode Capital Management ✦ (passief) | 7.14M | -0.2% | $7.36M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 9 | Goldman Sachs Group ✦ | 6.77M | n/a | $6.97M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 10 | JPMorgan Chase ✦ | 4.21M | n/a | $4.34M | 0.0% | n/c | 1 | SEC ↗ ×8 |
| 11 | Citadel Advisors ✦ | 3.86M | +4.0% | $3.97M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 12 | Millennium Management ✦ | 3.00M | +280.4% | $3.09M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 13 | Renaissance Technologies ✦ | 1.46M | +71.7% | $1.50M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 705.93K | +0.5% | $727,108 | 0.0% | ▲ Add | 6 | SEC ↗ ×4 |
| 15 | Point72 Asset Management ✦ | 368.26K | +11.1% | $379,310 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 16 | T. Rowe Price ✦ | 208.55K | -39.2% | $215,000 | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Geen nieuwe bijgehouden kopers dit kwartaal. |
Verlaten
| Wellington Management | $9.16M | was 0.0% |
| Marshall Wace | $3.41M | was 0.0% |
| Norges Bank | $3.30M | was 0.0% |
| Two Sigma Investments | $556,352 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 94 houders, 15.08M aandelen, $118.20M gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.